Javascript must be enabled to continue!
Alzheimer’s disease BIN1 coding variants increase intracellular Aβ by interfering with BACE1 recycling
View through CrossRef
ABSTRACT
Genetics identified
BIN1
as the second most important risk locus associated with late-onset Alzheimer’s disease, after APOE4. Here we show the consequences of two coding variants in BIN1 (rs754834233 and rs138047593), both in terms of intracellular beta-amyloid accumulation (iAbeta) and early endosome enlargement, two interrelated early cytopathological Alzheimer’s disease phenotypes, supporting their association with LOAD risk. We previously found that Bin1 deficiency potentiates beta-amyloid production by decreasing BACE1 recycling and enlarging early endosomes. Here, we demonstrate that the expression of the two LOAD mutant forms of Bin1 did not rescue the iAbeta accumulation and early endosome enlargement induced by Bin1 knockdown and recovered by wild-type Bin1. The LOAD coding variants reduced Bin1 interaction with BACE1 likely causing a dominant-negative effect since Bin1 mutants, but not wild-type Bin1, overexpression increased iAbeta42 due to defective BACE1 recycling and accumulation in early endosomes. Endocytic recycling of transferrin was similarly affected by Bin1 wild-type and mutants, indicating that Bin1 is a general regulator of endocytic recycling. These data show that the LOAD mutations in Bin1 lead to a loss of function, suggesting that endocytic recycling defects are an early causal mechanism of Alzheimer’s disease.
Title: Alzheimer’s disease BIN1 coding variants increase intracellular Aβ by interfering with BACE1 recycling
Description:
ABSTRACT
Genetics identified
BIN1
as the second most important risk locus associated with late-onset Alzheimer’s disease, after APOE4.
Here we show the consequences of two coding variants in BIN1 (rs754834233 and rs138047593), both in terms of intracellular beta-amyloid accumulation (iAbeta) and early endosome enlargement, two interrelated early cytopathological Alzheimer’s disease phenotypes, supporting their association with LOAD risk.
We previously found that Bin1 deficiency potentiates beta-amyloid production by decreasing BACE1 recycling and enlarging early endosomes.
Here, we demonstrate that the expression of the two LOAD mutant forms of Bin1 did not rescue the iAbeta accumulation and early endosome enlargement induced by Bin1 knockdown and recovered by wild-type Bin1.
The LOAD coding variants reduced Bin1 interaction with BACE1 likely causing a dominant-negative effect since Bin1 mutants, but not wild-type Bin1, overexpression increased iAbeta42 due to defective BACE1 recycling and accumulation in early endosomes.
Endocytic recycling of transferrin was similarly affected by Bin1 wild-type and mutants, indicating that Bin1 is a general regulator of endocytic recycling.
These data show that the LOAD mutations in Bin1 lead to a loss of function, suggesting that endocytic recycling defects are an early causal mechanism of Alzheimer’s disease.
Related Results
Proteomic characterization of the Alzheimer’s disease risk factor BIN1 interactome
Proteomic characterization of the Alzheimer’s disease risk factor BIN1 interactome
Abstract
The gene
BIN1
is the second-largest genetic risk factor for late-onset Alzheimer’s disease (LOAD). I...
Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy
Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy
In over a century since its discovery, Alzheimer’s disease (AD) has continued to be a global health concern due to its incurable nature and overwhelming increase among older people...
Identification of Novel Natural BACE1 Inhibitors for Alzheimer's Disease via In Silico Approach
Identification of Novel Natural BACE1 Inhibitors for Alzheimer's Disease via In Silico Approach
Background: Alzheimer's disease (AD) is a neurological ailment that causes progressive memory loss as neurons die. Beta-secretase 1 (BACE1) is a key enzyme in the production of amy...
BIN1 overexpression rescues cardiac but not skeletal muscle defects in a mouse model of caveolinopathy
BIN1 overexpression rescues cardiac but not skeletal muscle defects in a mouse model of caveolinopathy
ABSTRACT
Background
Mutations in
CAV3
, encoding caveolin-3, cause...
Lnc BACE1-AS Promotes The Progression of Osteosarcoma Through miR-762/SOX7 Axis
Lnc BACE1-AS Promotes The Progression of Osteosarcoma Through miR-762/SOX7 Axis
Abstract
Background: Osteosarcoma (OS) is a rare malignant primary tumor of mesenchymal origin affecting bone that occurs in adolescents and children. LncRNAs are important...
Link of BIN1, CLU, and fIDE Gene Polymorphisms with the Susceptibility
of Alzheimer’s Disease: Evidence from a Meta-analysis
Link of BIN1, CLU, and fIDE Gene Polymorphisms with the Susceptibility
of Alzheimer’s Disease: Evidence from a Meta-analysis
Background:
Alzheimer’s disease (AD) is the most common form of neurodegenerative disorder.
The association of BIN1, CLU, and IDE genetic polymorphisms with AD risk have been evalu...
Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels
Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels
Beta-site amyloid precursor protein (APP) cleaving enzyme1 (BACE1) catalyzes the rate-limiting step of amyloid-β protein (Aβ) generation, and is considered as a prime target for Al...
Discovery of Sulforaphane as a Potent BACE1 Inhibitor Based on Kinetics and Computational Studies
Discovery of Sulforaphane as a Potent BACE1 Inhibitor Based on Kinetics and Computational Studies
BACE1 is the rate-limiting enzyme involved in the production and deposition of β-amyloid (Aβ). Since neurotoxic Aβ plays a critical role in Alzheimer’s disease (AD) pathogenesis, B...

